Early quantification of the therapeutic efficacy of the vascular disrupting agent, CKD-516, using dynamic contrast-enhanced ultrasonography in rabbit VX2 liver tumors

PURPOSE: To evaluate the usefulness of dynamic contrast-enhanced ultrasonography (DCE-US) in the early quantification of hemodynamic change following administration of the vascular disrupting agent (VDA) CKD-516 using a rabbit VX2 liver tumor model. METHODS: This study was approved by our institutio...

Descripción completa

Detalles Bibliográficos
Autores principales: Joo, Ijin, Kim, Jung Hoon, Lee, Jeong Min, Choi, Jin Woo, Han, Joon Koo, Choi, Byung Ihn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Ultrasound in Medicine 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058966/
https://www.ncbi.nlm.nih.gov/pubmed/24936491
http://dx.doi.org/10.14366/usg.13006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058966/
https://www.ncbi.nlm.nih.gov/pubmed/24936491
http://dx.doi.org/10.14366/usg.13006

Ejemplares similares